Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1260530-41-3

Post Buying Request

1260530-41-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine-4-acetic acid, 6-(4-chlorophenyl)-8-Methoxy-1-Methyl-, Methyl ester

    Cas No: 1260530-41-3

  • No Data

  • No Data

  • No Data

  • GZ HONESTCHEM CO., LTD
  • Contact Supplier

1260530-41-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1260530-41-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,0,5,3 and 0 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1260530-41:
(9*1)+(8*2)+(7*6)+(6*0)+(5*5)+(4*3)+(3*0)+(2*4)+(1*1)=113
113 % 10 = 3
So 1260530-41-3 is a valid CAS Registry Number.

1260530-41-3Relevant articles and documents

New Synthetic Routes to Triazolo-benzodiazepine Analogues: Expanding the Scope of the Bump-and-Hole Approach for Selective Bromo and Extra-Terminal (BET) Bromodomain Inhibition

Baud, Matthias G. J.,Lin-Shiao, Enrique,Zengerle, Michael,Tallant, Cynthia,Ciulli, Alessio

, p. 1492 - 1500 (2016/03/08)

We describe new synthetic routes developed toward a range of substituted analogues of bromo and extra-terminal (BET) bromodomain inhibitors I-BET762/JQ1 based on the triazolo-benzodiazepine scaffold. These new routes allow for the derivatization of the me

Discovery and characterization of small molecule inhibitors of the BET family bromodomains

Chung, Chun-Wa,Coste, Hervé,White, Julia H.,Mirguet, Olivier,Wilde, Jonathan,Gosmini, Romain L.,Delves, Chris,Magny, Sylvie M.,Woodward, Robert,Hughes, Stephen A.,Boursier, Eric V.,Flynn, Helen,Bouillot, Anne M.,Bamborough, Paul,Brusq, Jean-Marie G.,Gellibert, Franc-Oise J.,Jones, Emma J.,Riou, Alizon M.,Homes, Paul,Martin, Sandrine L.,Uings, Iain J.,Toum, Jér?me,Clément, Catherine A.,Boullay, Anne-Bénédicte,Grimley, Rachel L.,Blandel, Florence M.,Prinjha, Rab K.,Lee, Kevin,Kirilovsky, Jorge,Nicodeme, Edwige

, p. 3827 - 3838 (2011/08/07)

Epigenetic mechanisms of gene regulation have a profound role in normal development and disease processes. An integral part of this mechanism occurs through lysine acetylation of histone tails which are recognized by bromodomains. While the biological and structural characterization of many bromodomain containing proteins has advanced considerably, the therapeutic tractability of this protein family is only now becoming understood. This paper describes the discovery and molecular characterization of potent (nM) small molecule inhibitors that disrupt the function of the BET family of bromodomains (Brd2, Brd3, and Brd4). By using a combination of phenotypic screening, chemoproteomics, and biophysical studies, we have discovered that the protein-protein interactions between bromodomains and acetylated histones can be antagonized by selective small molecules that bind at the acetylated lysine recognition pocket. X-ray crystal structures of compounds bound into bromodomains of Brd2 and Brd4 elucidate the molecular interactions of binding and explain the precisely defined stereochemistry required for activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1260530-41-3